Search Results - "Ortı́n, Xavier"
-
1
Fostamatinib effectiveness and safety for immune thrombocytopenia in clinical practice
Published in Blood (08-08-2024)“…•Similar to clinical trial results, fostamatinib has demonstrated a high efficacy rate for ITP in daily clinical practice conditions.•Fostamatinib is a…”
Get full text
Journal Article -
2
Low frequency of anti‐D alloimmunization following D+ platelet transfusion: the Anti‐D Alloimmunization after D‐incompatible Platelet Transfusions (ADAPT) study
Published in British journal of haematology (01-02-2015)“…Summary The reported frequency of D alloimmunization in D− recipients after transfusion of D+ platelets varies. This study was designed to determine the…”
Get full text
Journal Article -
3
Survival improvement of patients with FLT3 mutated acute myeloid leukemia: results from a prospective 9 years cohort
Published in Blood cancer journal (New York) (05-05-2023)“…Midostaurin added to intensive chemotherapy is the standard of care for acute myeloid leukemia (AML) with FLT3 mutations ( FLT3 mut). We analyzed the impact of…”
Get full text
Journal Article -
4
Genetic characterization of acute myeloid leukemia patients with mutations in IDH1/2 genes
Published in Leukemia research (01-02-2021)“…•IDH1/2 cases account for 23% of the studied cohort.•Mutual exclusivity was confirmed for IDH1 and IDH2 mutations.•IDH1 (86%) and IDH2 (89%) mutations…”
Get full text
Journal Article -
5
Feasibility and results of subtype-oriented protocols in older adults and fit elderly patients with acute lymphoblastic leukemia: Results of three prospective parallel trials from the PETHEMA group
Published in Leukemia research (01-02-2016)“…Highlights • Imatinib and low-dose chemotherapy was effective in older adults and elderly patients with Ph-positive ALL. • Rituximab and specific chemotherapy…”
Get full text
Journal Article -
6
The poor prognosis of low hypodiploidy in adults with B‐cell precursor acute lymphoblastic leukaemia is restricted to older adults and elderly patients
Published in British journal of haematology (01-07-2019)“…Summary The prognostic significance of low‐hypodiploidy has not been extensively evaluated in minimal residual disease (MRD)‐oriented protocols for adult acute…”
Get full text
Journal Article -
7
P531: MIDOSTAURIN PLUS 7 + 3 OR QUIZARTINIB PLUS 7 + 3 IN FLT3-ITD MUTATED AML
Published in HemaSphere (08-08-2023)Get full text
Journal Article -
8
Hydroxyethylstarch as a replacement fluid in therapeutic plasma exchange for lupus nephritis in a Jehovah’s Witness
Published in Transfusion and apheresis science (01-02-2003)Get full text
Journal Article -
9
Bemiparin Versus Unfractionated Heparin as Bridging Therapy in the Perioperative Management of Patients on Vitamin K Antagonists: The BERTA Study
Published in Clinical drug investigation (01-12-2013)“…Background and Objective The management of patients on vitamin K antagonist therapy who require an invasive procedure is problematic. A randomised, controlled,…”
Get full text
Journal Article -
10
Results of the PETHEMA ALL-96 trial in elderly patients with Philadelphia chromosome-negative acute lymphoblastic leukemia
Published in European journal of haematology (01-02-2007)“…Background and aim: Only 20–30% of elderly patients with acute lymphoblastic leukemia (ALL) are enrolled in clinical trials because of co‐morbid disorders or…”
Get full text
Journal Article -
11
Identification of recent HIV-1 infection among newly diagnosed cases in Catalonia, Spain (2006-08)
Published in European journal of public health (01-12-2012)“…Quantification and description of patients recently infected by HIV can provide an accurate estimate of the dynamics of HIV transmission. Between 2006 and 2008…”
Get full text
Journal Article -
12
Postpartum ovarian vein thrombosis
Published in Thrombosis and haemostasis (01-05-2005)Get more information
Journal Article -
13
BCL3 rearrangements in B-cell lymphoid neoplasms occur in two breakpoint clusters associated with different diseases
Published in Haematologica (Roma) (01-02-2024)“…The t(14;19)(q32;q13) often juxtaposes BCL3 with immunoglobulin heavy chain (IGH) resulting in overexpression of the gene. In contrast to other oncogenic…”
Get full text
Journal Article -
14
Use of polyethylene glycol for performing autologous adsorptions
Published in Transfusion (Philadelphia, Pa.) (01-05-2005)“…BACKGROUND: Our reference adsorption procedure is to autoadsorb serum with ZZAP‐pretreated patients’ red cells (RBCs), although it is time‐consuming. The aim…”
Get full text
Journal Article -
15
Acute liver failure as the first manifestation of very late relapsing of Hodgkin's disease
Published in Hematology reports (23-07-2010)“…Hodgkin's disease is, in general, a lymph node-based disease. It usually starts in an area within the lymphatic system and spreads, in an orderly manner, along…”
Get full text
Journal Article -
16
Stroke in a Multiple Myeloma Patient Treated With Thalidomide
Published in Journal of stroke and cerebrovascular diseases (01-11-2006)“…The antiangiogenic and immunomodulatory properties of thalidomide have led to its use and evaluation in refractory or relapsed multiple myeloma (MM). 1,2…”
Get full text
Journal Article -
17
Prospective Population-Based Analysis of Characteristics and Therapy Options in AML: The Case of Catalonia (PERIS Project)
Published in Blood (05-11-2020)“…Introduction:Acute myeloid leukemia (AML) real-world incidence has been investigated in a limited number of European countries such as Sweden, Denmark and a…”
Get full text
Journal Article -
18
Risk-Adapted Intensive Chemotherapy for Primary ACUTE Myeloid Leukemia during the Last 25 YEARS: Increase in Complete Remission RATE, Hematopoietic Cell Transplantation Access and Decrease in Relapse Incidence Have LED to Improved Survival
Published in Blood (05-11-2020)“…The progress in the understanding of pathophysiology of AML has allowed the identification of genetic and immune abnormalities with prognostic impact on…”
Get full text
Journal Article -
19
Final Results of the AML12 Trial of the Spanish Cetlam Group in Adults with Acute Myeloid Leukemia (AML) up to the Age of 70 Years: Risk Adapted Post-Remission Allocation Based on Genetic Data and Minimal Residual Disease
Published in Blood (13-11-2019)“…BACKGROUND: AML risk classification is based on genetics (cytogenetics and molecular features) and more recently also on minimal residual disease (MRD) after…”
Get full text
Journal Article -
20
Monocyte chemoattractant protein-1 and paraoxonase-1 and 3 levels in patients with sepsis treated in an intensive care unit: a preliminary report
Published in Clinical chemistry and laboratory medicine (01-08-2012)“…There is considerable interest in the research of molecules modulating the acute inflammatory response in patients with sepsis. Paraoxonases (PON) are…”
Get more information
Journal Article